Unknown

Dataset Information

0

Chronic sleep restriction in the rotenone Parkinson's disease model in rats reveals peripheral early-phase biomarkers.


ABSTRACT: Parkinson's disease (PD) is a chronic disorder that presents a range of premotor signs, such as sleep disturbances and cognitive decline, which are key non-motor features of the disease. Increasing evidence of a possible association between sleep disruption and the neurodegenerative process suggests that sleep impairment could produce a detectable metabolic signature on the disease. In order to integrate neurocognitive and metabolic parameters, we performed untargeted and targeted metabolic profiling of the rotenone PD model in a chronic sleep restriction (SR) (6 h/day for 21 days) condition. We found that SR combined with PD altered several behavioural (reversal of locomotor activity impairment; cognitive impairment; delay of rest-activity rhythm) and metabolic parameters (branched-chain amino acids, tryptophan pathway, phenylalanine, and lipoproteins, pointing to mitochondrial impairment). If combined, our results bring a plethora of parameters that represents reliable early-phase PD biomarkers which can easily be measured and could be translated to human studies.

SUBMITTER: Fagotti J 

PROVIDER: S-EPMC6374389 | BioStudies | 2019-01-01

REPOSITORIES: biostudies

Similar Datasets

2014-01-01 | S-EPMC4249459 | BioStudies
2009-01-01 | S-EPMC2757935 | BioStudies
1000-01-01 | S-EPMC5837210 | BioStudies
2013-01-01 | S-EPMC3729741 | BioStudies
2018-01-01 | S-EPMC5912054 | BioStudies
2014-01-01 | S-EPMC3893822 | BioStudies
1000-01-01 | S-EPMC5577282 | BioStudies
2009-01-01 | S-EPMC2696567 | BioStudies
2007-01-01 | S-EPMC2000881 | BioStudies
2020-01-01 | S-EPMC7646065 | BioStudies